2023 pediatric dermatology research alliance (pedra) annual conference
Ended Project Grant Awarded Last action
- Award ID
- R13AR083807
- Recipient
-
Pediatric Dermatology Research Alliance Inc. UEI NEWJWX2BLE73
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $72,175
Award facts
- Assistance listing
- 93.846 Arthritis, Musculoskeletal and Skin Diseases Research
- Completion date
- Place of performance
- Oregon, USA
Award details come from USAspending.gov.
Description
- Abstract
- Pediatric dermatology is a relatively young specialty that has lacked robust data about the natural history and long-term outcomes of skin disorders that begin in infancy and childhood. In addition, evidence-based guidelines of care, standardized treatment protocols, and FDA-approved therapies for the majority of pediatric dermatologic disorders are sparse. The pediatric dermatology research alliance (pedra) was founded in 2012 to address these crucial yet unmet needs. Pedra's primary mission is to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease. The long-term goal of pedra is to leverage such research to improve the health outcomes of children with skin disorders. Annual conferences have been integral to the success of pedra, providing a forum for educating investigators, identifying and prioritizing research needs and opportunities, and developing and initiating innovative projects. A combination of didactic lectures and panels, expert-led small group discussions, poster sessions, and unique training opportunities are the foundation of every pedra annual conference. This proposal is for the 11TH pedra annual conference, set to take place in november of 2023 with the following aims: 1) provide education and engagement opportunities with a focus on patient-centricity, innovation, and cross-cutting collaboration to advance science, while integrating equity, diversity, and inclusion across pediatric dermatology research; 2) advance existing research projects and develop new research priorities and initiatives in disease-areas and high-priority topics spanning the field of pediatric dermatology; and 3) provide a forum for the dissemination of final and ongoing research results from a broad group of investigators to a diverse audience that includes patient stakeholders, industry representatives, and researchers from multiple fields including potential NIH collaborators. The expected outcomes of this conferrencer are a more developed set of research skills for current and future physician-scientists, enhanced productivity, strengthened multi-stakeholder networks, and the conduct of high- quality research. These activities will accelerate the pace of pediatric dermatology research, allowing clinicians to better understand, prevent and treat skin disease in children, and giving patients and families options to manage diseases and make informed treatment decisions in the future.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $72,175 |
Quick answers
Who received award R13AR083807?
R13AR083807 was awarded to Pediatric Dermatology Research Alliance Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 18, 2023.
How much is award R13AR083807 worth?
$72,175 has been obligated on R13AR083807.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award